

The active ingredient of the solution Prolatan - prostaglandin latanoprost, which is an analogue of prostaglandin F 2α. Its action leads to a decrease in intraocular pressure, which is achieved by increasing the outflow of aqueous humor (uveoscleral outflow). According to the results of clinical studies, the drug has no significant effect on the amount of produced intraocular moisture, does not affect the hematophthalmic barrier.
Source - the Moscow Eye Clinic website: http://mgkl.ru/patient/aptechka/prolatan
Active substance: latanoprost - 0.05 mg.
Auxiliary components: sodium monohydrate, benzalkonium chloride, disodium hydrogen phosphate, sodium chloride, water.
Latanoprost is marketed under different brands and generic names, and comes in different dosage forms:
Brand name | Manufacturer | Country | Dosage form |
---|---|---|---|
Trilactane | eye drops | ||
Prolatan | Sentiss Pharma | India | eye drops |
Xalatamax | Jadran-Galensky Laboratories ao | Croatia | eye drops |
Gomamax | Kevelt AO | Estonia | drops |
Glauprost | K.O.Romparm Company S.R.L | Romania | eye drops |
Xalatan | Pfizer | USA | eye drops |
No customer reviews for the moment.
For adult patients and children after 1 year, the standard dosage is one drop of Prolatan solution once a day in the affected eye conjunctival. The optimal effect is achieved if the drug is used in the evening. When skipping a dose, the next one is administered at the usual time.
Source - the Moscow Eye Clinic website: http://mgkl.ru/patient/aptechka/prolatan
With care solution Prolatan should be appointed at: aphakia, pseudo-aphakia and rupture of the back capsule lens; macular edema (including anamnesis); congenital, neovascular, inflammatory glaucoma; asthma; herpetic keratitis.
For overdose with Prolatan solution, reddening of the conjunctiva and episclera, nausea, abdominal pain, sweating, flushing, fatigue, dizziness are characteristic. If necessary, symptomatic therapy should be carried out.
Studies and clinical trials of Latanoprost (Click to expand)